MUC5AC
Mucin-5AC
Also known as: MUC5, MUC5A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P98088
- Gene
- MUC5AC
- Ensembl
- ENSG00000215182
- Chromosome
- 11
- Canonical length
- 5654 aa
- Protein class
- Predicted secreted proteins
- Subcellular location
- Vesicles
- Secretome location
- Secreted to digestive system
- Quaternary structure
- Homomultimer
OverviewNCBI Gene
Predicted to enable extracellular matrix constituent, lubricant activity. Predicted to be an extracellular matrix structural constituent. Predicted to act upstream of or within maintenance of lens transparency. Located in extracellular space and mucus layer. Implicated in dry eye syndrome. Biomarker of several diseases, including Sjogren's syndrome; biliary tract disease (multiple); cystic fibrosis; eye disease (multiple); and pancreatic cancer (multiple). [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
5654 residues, UniProt reviewed canonical sequence.
>P98088|MUC5AC
1 MSVGRRKLAL LWALALALAC TRHTGHAQDG SSESSYKHHP ALSPIARGPS GVPLRGATVF
61 PSLRTIPVVR ASNPAHNGRV CSTWGSFHYK TFDGDVFRFP GLCNYVFSEH CGAAYEDFNI
121 QLRRSQESAA PTLSRVLMKV DGVVIQLTKG SVLVNGHPVL LPFSQSGVLI QQSSSYTKVE
181 ARLGLVLMWN HDDSLLLELD TKYANKTCGL CGDFNGMPVV SELLSHNTKL TPMEFGNLQK
241 MDDPTDQCQD PVPEPPRNCS TGFGICEELL HGQLFSGCVA LVDVGSYLEA CRQDLCFCED
301 TDLLSCVCHT LAEYSRQCTH AGGLPQDWRG PDFCPQKCPN NMQYHECRSP CADTCSNQEH
361 SRACEDHCVA GCFCPEGTVL DDIGQTGCVP VSKCACVYNG AAYAPGATYS TDCTNCTCSG
421 GRWSCQEVPC PGTCSVLGGA HFSTFDGKQY TVHGDCSYVL TKPCDSSAFT VLAELRRCGL
481 TDSETCLKSV TLSLDGAQTV VVIKASGEVF LNQIYTQLPI SAANVTIFRP STFFIIAQTS
541 LGLQLNLQLV PTMQLFMQLA PKLRGQTCGL CGNFNSIQAD DFRTLSGVVE ATAAAFFNTF
601 KTQAACPNIR NSFEDPCSLS VENEKYAQHW CSQLTDADGP FGRCHAAVKP GTYYSNCMFD
661 TCNCERSEDC LCAALSSYVH ACAAKGVQLG GWRDGVCTKP MTTCPKSMTY HYHVSTCQPT
721 CRSLSEGDIT CSVGFIPVDG CICPKGTFLD DTGKCVQASN CPCYHRGSMI PNGESVHDSG
781 AICTCTHGKL SCIGGQAPAP VCAAPMVFFD CRNATPGDTG AGCQKSCHTL DMTCYSPQCV
841 PGCVCPDGLV ADGEGGCITA EDCPCVHNEA SYRAGQTIRV GCNTCTCDSR MWRCTDDPCL
901 ATCAVYGDGH YLTFDGQSYS FNGDCEYTLV QNHCGGKDST QDSFRVVTEN VPCGTTGTTC
961 SKAIKIFLGG FELKLSHGKV EVIGTDESQE VPYTIRQMGI YLVVDTDIGL VLLWDKKTSI
1021 FINLSPEFKG RVCGLCGNFD DIAVNDFATR SRSVVGDVLE FGNSWKLSPS CPDALAPKDP
1081 CTANPFRKSW AQKQCSILHG PTFAACHAHV EPARYYEACV NDACACDSGG DCECFCTAVA
1141 AYAQACHEVG LCVSWRTPSI CPLFCDYYNP EGQCEWHYQP CGVPCLRTCR NPRGDCLRDV
1201 RGLEGCYPKC PPEAPIFDED KMQCVATCPT PPLPPRCHVH GKSYRPGAVV PSDKNCQSCL
1261 CTERGVECTY KAEACVCTYN GQRFHPGDVI YHTTDGTGGC ISARCGANGT IERRVYPCSP
1321 TTPVPPTTFS FSTPPLVVSS THTPSNGPSS AHTGPPSSAW PTTAGTSPRT RLPTASASLP
1381 PVCGEKCLWS PWMDVSRPGR GTDSGDFDTL ENLRAHGYRV CESPRSVECR AEDAPGVPLR
1441 ALGQRVQCSP DVGLTCRNRE QASGLCYNYQ IRVQCCTPLP CSTSSSPAQT TPPTTSKTTE
1501 TRASGSSAPS STPGTVSLST ARTTPAPGTA TSVKKTFSTP SPPPVPATST SSMSTTAPGT
1561 SVVSSKPTPT EPSTSSCLQE LCTWTEWIDG SYPAPGINGG DFDTFQNLRD EGYTFCESPR
1621 SVQCRAESFP NTPLADLGQD VICSHTEGLI CLNKNQLPPI CYNYEIRIQC CETVNVCRDI
1681 TRLPKTVATT RPTPHPTGAQ TQTTFTTHMP SASTEQPTAT SRGGPTATSV TQGTHTTLVT
1741 RNCHPRCTWT KWFDVDFPSP GPHGGDKETY NNIIRSGEKI CRRPEEITRL QCRAKSHPEV
1801 SIEHLGQVVQ CSREEGLVCR NQDQQGPFKM CLNYEVRVLC CETPRGCHMT STPGSTSSSP
1861 AQTTPSTTSK TTETQASGSS APSSTPGTVS LSTARTTPAP GTATSVKKTF STPSPPPVPA
1921 TSTSSMSTTA PGTSVVSSKP TPTEPSTSSC LQELCTWTEW IDGSYPAPGI NGGDFDTFQN
1981 LRDEGYTFCE SPRSVQCRAE SFPNTPLADL GQDVICSHTE GLICLNKNQL PPICYNYEIR
2041 IQCCETVNVC RDITRPPKTV ATTRPTPHPT GAQTQTTFTT HMPSASTEQP TATSRGGPTA
2101 TSVTQGTHTT PVTRNCHPRC TWTTWFDVDF PSPGPHGGDK ETYNNIIRSG EKICRRPEEI
2161 TRLQCRAKSH PEVSIEHLGQ VVQCSREEGL VCRNQDQQGP FKMCLNYEVR VLCCETPKGC
2221 PVTSTPVTAP STPSGRATSP TQSTSSWQKS RTTTLVTTST TSTPQTSTTY AHTTSTTSAP
2281 TARTTSAPTT RTTSASPAST TSGPGNTPSP VPTTSTISAP TTSITSAPTT STTSAPTSST
2341 TSGPGTTPSP VPTTSITSAP TTSTTSAPTT STTSARTSST TSATTTSRIS GPETTPSPVP
2401 TTSTTSATTT STTSAPTTST TSAPTSSTTS SPQTSTTSAP TTSTTSGPGT TPSPVPTTST
2461 TSAPTTRTTS APKSSTTSAA TTSTTSGPET TPRPVPTTST TSSPTTSTTS APTTSTTSAS
2521 TTSTTSGAGT TPSPVPTTST TSAPTTSTTS APISSTTSAT TTSTTSGPGT TPSPVPTTST
2581 TSAPTTSTTS GPGTTPSAVP TTSITSAPTT STNSAPISST TSATTTSRIS GPETTPSPVP
2641 TASTTSASTT STTSGPGTTP SPVPTTSTIS VPTTSTTSAS TTSTTSASTT STTSGPGTTP
2701 SPVPTTSTTS APTTSTTSAP TTSTISAPTT STTSATTTST TSAPTPRRTS APTTSTISAS
2761 TTSTTSATTT STTSATTTST ISAPTTSTTL SPTTSTTSTT ITSTTSAPIS STTSTPQTST
2821 TSAPTTSTTS GPGTTSSPVP TTSTTSAPTT STTSAPTTRT TSVPTSSTTS TATTSTTSGP
2881 GTTPSPVPTT STTSAPTTRT TSAPTTSTTS APTTSTTSAP TSSTTSATTT STISVPTTST
2941 TSVPGTTPSP VPTTSTISVP TTSTTSASTT STTSGPGTTP SPVPTTSTTS APTTSTTSAP
3001 TTSTISAPTT STPSAPTTST TLAPTTSTTS APTTSTTSTP TSSTTSSPQT STTSASTTSI
3061 TSGPGTTPSP VPTTSTTSAP TTSTTSAATT STISAPTTST TSAPTTSTTS ASTASKTSGL
3121 GTTPSPIPTT STTSPPTTST TSASTASKTS GPGTTPSPVP TTSTIFAPRT STTSASTTST
3181 TPGPGTTPSP VPTTSTASVS KTSTSHVSIS KTTHSQPVTR DCHLRCTWTK WFDIDFPSPG
3241 PHGGDKETYN NIIRSGEKIC RRPEEITRLQ CRAESHPEVS IEHLGQVVQC SREEGLVCRN
3301 QDQQGPFKMC LNYEVRVLCC ETPKGCPVTS TPVTAPSTPS GRATSPTQST SSWQKSRTTT
3361 LVTTSTTSTP QTSTTSAPTT STTSAPTTST TSAPTTSTTS TPQTSISSAP TSSTTSAPTS
3421 STISARTTSI ISAPTTSTTS SPTTSTTSAT TTSTTSAPTS STTSTPQTSK TSAATSSTTS
3481 GSGTTPSPVT TTSTASVSKT STSHVSVSKT THSQPVTRDC HPRCTWTKWF DVDFPSPGPH
3541 GGDKETYNNI IRSGEKICRR PEEITRLQCR AKSHPEVSIE HLGQVVQCSR EEGLVCRNQD
3601 QQGPFKMCLN YEVRVLCCET PKGCPVTSTS VTAPSTPSGR ATSPTQSTSS WQKSRTTTLV
3661 TSSITSTTQT STTSAPTTST TPASIPSTTS APTTSTTSAP TTSTTSAPTT STTSTPQTTT
3721 SSAPTSSTTS APTTSTISAP TTSTISAPTT STTSAPTAST TSAPTSTSSA PTTNTTSAPT
3781 TSTTSAPITS TISAPTTSTT STPQTSTISS PTTSTTSTPQ TSTTSSPTTS TTSAPTTSTT
3841 SAPTTSTTST PQTSISSAPT SSTTSAPTAS TISAPTTSTT SFHTTSTTSP PTSSTSSTPQ
3901 TSKTSAATSS TTSGSGTTPS PVPTTSTASV SKTSTSHVSV SKTTHSQPVT RDCHPRCTWT
3961 KWFDVDFPSP GPHGGDKETY NNIIRSGEKI CRRPEEITRL QCRAESHPEV SIEHLGQVVQ
4021 CSREEGLVCR NQDQQGPFKM CLNYEVRVLC CETPKGCPVT STPVTAPSTP SGRATSPTQS
4081 TSSWQKSRTT TLVTTSTTST PQTSTTSAPT TSTIPASTPS TTSAPTTSTT SAPTTSTTSA
4141 PTHRTTSGPT TSTTLAPTTS TTSAPTTSTN SAPTTSTISA STTSTISAPT TSTISSPTSS
4201 TTSTPQTSKT SAATSSTTSG SGTTPSPVPT TSTTSASTTS TTSAPTTSTT SGPGTTPSPV
4261 PSTSTTSAAT TSTTSAPTTR TTSAPTSSMT SGPGTTPSPV PTTSTTSAPT TSTTSGPGTT
4321 PSPVPTTSTT SAPITSTTSG PGSTPSPVPT TSTTSAPTTS TTSASTASTT SGPGTTPSPV
4381 PTTSTTSAPT TRTTSASTAS TTSGPGSTPS PVPTTSTTSA PTTRTTPAST ASTTSGPGTT
4441 PSPVPTTSTT SASTTSTISL PTTSTTSAPI TSMTSGPGTT PSPVPTTSTT SAPTTSTTSA
4501 STASTTSGPG TTPSPVPTTS TTSAPTTSTT SASTASTTSG PGTSLSPVPT TSTTSAPTTS
4561 TTSGPGTTPS PVPTTSTTSA PTTSTTSGPG TTPSPVPTTS TTPVSKTSTS HLSVSKTTHS
4621 QPVTSDCHPL CAWTKWFDVD FPSPGPHGGD KETYNNIIRS GEKICRRPEE ITRLQCRAES
4681 HPEVNIEHLG QVVQCSREEG LVCRNQDQQG PFKMCLNYEV RVLCCETPRG CPVTSVTPYG
4741 TSPTNALYPS LSTSMVSASV ASTSVASSSV ASSSVAYSTQ TCFCNVADRL YPAGSTIYRH
4801 RDLAGHCYYA LCSQDCQVVR GVDSDCPSTT LPPAPATSPS ISTSEPVTEL GCPNAVPPRK
4861 KGETWATPNC SEATCEGNNV ISLRPRTCPR VEKPTCANGY PAVKVADQDG CCHHYQCQCV
4921 CSGWGDPHYI TFDGTYYTFL DNCTYVLVQQ IVPVYGHFRV LVDNYFCGAE DGLSCPRSII
4981 LEYHQDRVVL TRKPVHGVMT NEIIFNNKVV SPGFRKNGIV VSRIGVKMYA TIPELGVQVM
5041 FSGLIFSVEV PFSKFANNTE GQCGTCTNDR KDECRTPRGT VVASCSEMSG LWNVSIPDQP
5101 ACHRPHPTPT TVGPTTVGST TVGPTTVGST TVGPTTPPAP CLPSPICQLI LSKVFEPCHT
5161 VIPPLLFYEG CVFDRCHMTD LDVVCSSLEL YAALCASHDI CIDWRGRTGH MCPFTCPADK
5221 VYQPCGPSNP SYCYGNDSAS LGALPEAGPI TEGCFCPEGM TLFSTSAQVC VPTGCPRCLG
5281 PHGEPVKVGH TVGMDCQECT CEAATWTLTC RPKLCPLPPA CPLPGFVPVP AAPQAGQCCP
5341 QYSCACNTSR CPAPVGCPEG ARAIPTYQEG ACCPVQNCSW TVCSINGTLY QPGAVVSSSL
5401 CETCRCELPG GPPSDAFVVS CETQICNTHC PVGFEYQEQS GQCCGTCVQV ACVTNTSKSP
5461 AHLFYPGETW SDAGNHCVTH QCEKHQDGLV VVTTKKACPP LSCSLDEARM SKDGCCRFCP
5521 PPPPPYQNQS TCAVYHRSLI IQQQGCSSSE PVRLAYCRGN CGDSSSMYSL EGNTVEHRCQ
5581 CCQELRTSLR NVTLHCTDGS SRAFSYTEVE ECGCMGRRCP APGDTQHSEE AEPEPSQEAE
5641 SGSWERGVPV SPMHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MUC5AC can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0
- Highest tissue expression
- 175 nTPM
Expression across tissuesHPA
Tissue
- stomach: 175 nTPM
- cervix: 1.7 nTPM
- lung: 1.5 nTPM
- gallbladder: 1.3 nTPM
- pancreas: 0.7 nTPM
- esophagus: 0.3 nTPM
Single-cell type
- foveolar cells: 86 nCPM
- conjunctival goblet cells: 79 nCPM
- prostatic club cells: 8.5 nCPM
- respiratory deuterosomal cells: 5.2 nCPM
- respiratory secretory cells: 5 nCPM
- endometrial secretory cells: 4.5 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- cerebral cortex: 0 nTPM
- choroid plexus: 0 nTPM
- hippocampal formation: 0 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MUC5AC.
Disease | ImmuneIEDB
Conditions an epitope on MUC5AC was assayed in.
- melanoma T cell
- cholangiocarcinoma T cell
ReferencesPubMed · IEDB
Publications for MUC5AC from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
- Humoral immune response to MUC5AC in patients with colorectal polyps and colorectal carcinoma.
2006 · BMC Gastroenterol · RCR 0.6 · 25 citations
Reference: T cellIEDB
2 publications
- Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma.
2020 · Elife · RCR 0.6 · 17 citations - Immune responses against tumour-associated antigen-derived cytotoxic T lymphocyte epitopes in cholangiocarcinoma patients.
2018 · Liver Int · RCR 0.4 · 14 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.84
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.26
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- VWFC domain
- von Willebrand factor, type D domain
- Trypsin Inhibitor-like, cysteine rich domain
- Cystine knot, C-terminal
- VWF/SSPO/Zonadhesin-like, cysteine-rich domain
- WxxW domain
- Serine protease inhibitor-like superfamily
- Mucin/von Willebrand/Thrombospondin superfamily
- Otogelin-like/Mucin, TIL domain
- von Willebrand factor type D domain
- Trypsin Inhibitor like cysteine rich domain
- C8 domain
- Mucin-2 protein WxxW repeating region
- Otogelin-like/Mucin TIL domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MUC5AC as an antibody target. Whether an autoantibody or antibody against MUC5AC could matter depends on whether native MUC5AC is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MUC5AC is annotated as secreted, so native MUC5AC circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label MUC5AC as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...